Endocarditis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
}} | }} | ||
{{Infective endocarditis}} | {{Infective endocarditis}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}; [[Michael W. Tempelhof]] M.D. | {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}; [[Michael W. Tempelhof]] M.D. | ||
| Line 41: | Line 41: | ||
==[[Endocarditis prognosis|Prognosis]]== | ==[[Endocarditis prognosis|Prognosis]]== | ||
{{Circulatory system pathology}} | {{Circulatory system pathology}} | ||
[[tr:İnfektif endokardit]] | [[tr:İnfektif endokardit]] | ||
Revision as of 22:37, 17 August 2011
For patient information click here
| Endocarditis | |
 | |
|---|---|
| Mitral valve vegetations in a patient with bacterial endocarditis. | |
| ICD-10 | I33 |
| ICD-9 | 421 |
| DiseasesDB | 4224 |
| MeSH | D004696 |
|
Endocarditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease |
|
Case Studies |
|
Endocarditis On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Michael W. Tempelhof M.D.
Related Key Words and Synonyms: Infective Endocarditis(IE), Subacute bacterial endocarditis (SBE), Acute bacterial endocarditis, fungal endocarditis, nosocomial infective endocarditis, intravenous drug abuse endocarditis, intravenous drug abuse infective endocarditis, Prosthetic valve endocarditis, pacemaker endocarditis infective endocarditis, endocardial infection, native valve endocarditis, HACEK endocarditis, bloodstream infection, marantic endocarditis
Overview
Historical Perspective
Epidemiology and Demographics
Pathophysiology and Etiology
Diagnosis
Diagnostic Criteria | Differential Diagnosis of Underlying Causes | History and Symptoms | Physical Examination and Signs | Laboratory studies | Echocardiography
Treatment
Antibiotic Therapy | Antithrombotic Therapy | Surgical Indications | Surgical Treatment